Yayın:
Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats

dc.contributor.buuauthorHamurtekin, Emre
dc.contributor.buuauthorBağdaş, Deniz
dc.contributor.buuauthorGürun, M. Sibel
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFarmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
dc.contributor.researcheridAAG-8716-2019
dc.contributor.scopusid8717648500
dc.contributor.scopusid15062425700
dc.contributor.scopusid55664349700
dc.date.accessioned2022-10-31T06:40:25Z
dc.date.available2022-10-31T06:40:25Z
dc.date.issued2007-04-24
dc.description.abstractCytidine-5'-diphosphate choline (CDP-choline; citicoline) is an essential endogenous compound normally produced by the organism and is a source of cytidine and choline. Our recent studies on acute pain models demonstrate that intracerebroventricularly administered CDPcholine produces antinociception via supraspinal alpha-7 nicotinic acetylcholine receptors-mediated mechanism in rats. However, it remains to be elucidated which other supraspinal mechanisms are involved in the antinociceptive effect of CDP-choline. In this study, we investigated the role of the supraspinal opioidergic, GABAergic, alpha-adrenergic and serotonergic receptors in CDP-choline-induced antinociception. The antinociceptive effect of CDP-choline was evoked by the intracerebroventricular (i.c.v.) administration. Two different pain models were utilized: thermal paw withdrawal test and mechanical paw pressure test. The i.c.v. administration of CDP-choline (0.5, 1.0 and 2.0 mu mol) produced dose-dependent antinociception. Non-specific opioid receptor antagonist naloxone (10 mu g; i.c.v.) and GABA(B) receptor antagonist CGP-35348 (20 mu g; i.c.v.) pretreatments inhibited the antinociceptive effects of CDP-choline (1.0 mu mol; i.c.v.). In contrast, the alpha-1 adrenergic receptor antagonist prazosin (20 mu g; i.c.v.), alpha-2 adrenergic receptor antagonist yohimbine (30 mu g; i.c.v.) and non-specific scrotonin receptor antagonist methysergide (20 mu g; i.c.v.) pretreatments had no effect on CDP-choline-induced antinociception in the thermal paw withdrawal test and in the mechanical paw pressure test. Therefore, it can be postulated that i.c.v. administered CDP-choline exerts antinociceptive effect mediated by supraspinal opioid and GABAB receptors in acute pain models. Furthermore, supraspinal alpha-adrenergic and serotonergic receptors do not appear to be involved in the antinociceptive effect of CDP-choline.
dc.identifier.citationHamurtekin, E. vd. (2007). "Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats". Neuroscience Letters, 420(2), 116-121.
dc.identifier.doi10.1016/j.neulet.2007.04.058
dc.identifier.issn0304-3940
dc.identifier.issn1872-7972
dc.identifier.issue2
dc.identifier.pubmed17531379
dc.identifier.scopus2-s2.0-34249330701
dc.identifier.urihttps://doi.org/10.1016/j.neulet.2007.04.058
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0304394007005095
dc.identifier.urihttp://hdl.handle.net/11452/29261
dc.identifier.volume420
dc.identifier.wos000247405500005
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier Ireland
dc.relation.journalNeuroscience Letters
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGABA receptors
dc.subjectNicotinic acetylcholine-receptors
dc.subjectAlpha-7 nicotinic receptors
dc.subjectAntinociception
dc.subjectCDP-choline
dc.subjectOpioid receptors
dc.subjectPain
dc.subjectMorphine-induced antinociception
dc.subjectAnalgesic activity
dc.subjectAgonists
dc.subjectRelease
dc.subjectAntagonists
dc.subjectModulation
dc.subjectMechanisms
dc.subjectCiticoline
dc.subjectDiversity
dc.subjectNeurosciences & neurology
dc.subject.emtreeMale
dc.subject.emtreeAnalgesia
dc.subject.emtreeAnimal experiment
dc.subject.emtreeAnimal model
dc.subject.emtreeAntinociception
dc.subject.emtreeArticle
dc.subject.emtreeControlled study
dc.subject.emtreeExperimental model
dc.subject.emtreeNonhuman
dc.subject.emtreeSerotonin antagonist
dc.subject.emtreeMechanical stimulation
dc.subject.emtreePain
dc.subject.emtreeOpiate antagonist
dc.subject.emtreeRat
dc.subject.emtreeMethysergide
dc.subject.emtree3 aminopropyl(diethoxymethyl)phosphinic acid
dc.subject.emtreePriority journal
dc.subject.emtreeThermal stimulation
dc.subject.emtreeAlpha adrenergic receptor
dc.subject.emtreeCiticoline
dc.subject.emtree4 aminobutyric acid B receptor
dc.subject.emtree4 aminobutyric acid B receptor blocking agent
dc.subject.emtree4 aminobutyric acid receptor
dc.subject.emtreeAlpha 1 adrenergic receptor
dc.subject.emtreeAlpha 1 adrenergic receptor blocking agent
dc.subject.emtreeAlpha 2 adrenergic receptor
dc.subject.emtreeAlpha 2 adrenergic receptor blocking agent
dc.subject.emtreeNaloxone
dc.subject.emtreeOpiate receptor
dc.subject.emtreePrazosin
dc.subject.emtreeSerotonin receptor
dc.subject.emtreeYohimbine
dc.subject.meshAnalgesics
dc.subject.meshAcute disease
dc.subject.meshAdrenergic alpha-antagonists
dc.subject.meshAnimals
dc.subject.meshEfferent oathways
dc.subject.meshReceptors, GABA-B
dc.subject.meshBrain
dc.subject.meshCytidine diphosphate choline
dc.subject.meshDisease models, animal
dc.subject.meshGABA antagonists
dc.subject.meshReceptors, GABA
dc.subject.meshInjections,intraventricular
dc.subject.meshMale
dc.subject.meshReceptors,adrenergic, alpha
dc.subject.meshNarcotic antagonists
dc.subject.meshRats
dc.subject.meshRats, sprague-dawley
dc.subject.meshNociceptors
dc.subject.meshPain
dc.subject.meshPain measurement
dc.subject.meshPain threshold
dc.subject.meshReceptors, opioid
dc.subject.meshReceptors, serotonin
dc.subject.meshSerotonin antagonists
dc.subject.scopusCiticoline; Neuroprotective Agents; Glycerylphosphorylcholine
dc.subject.wosNeurosciences
dc.titlePossible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats
dc.typeArticle
dc.wos.quartileQ3
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama